Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Gilead Sciences, Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$83.4 Billion
Q1 2025

A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 533,240 shares of GILD stock, worth $57.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

533,240

Previous 300,074 77.7%

Holding current value

$57.2 Million

Previous $27.7 Million 115.57%

% of portfolio

0.07%

Previous 0.03%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$89.14 - $117.41 $20.8 Million - $27.4 Million	233,166 Added 77.7%	533,240 $59.7 Million
Q4 2024 Feb 14, 2025	SELL	$83.95 - $97.9 $6.19 Million - $7.21 Million	-73,686 Reduced 19.71%	300,074 $27.7 Million
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $1.62 Million - $2.05 Million	-24,370 Reduced 6.12%	373,760 $31.3 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $6.54 Million - $7.54 Million	103,490 Added 35.12%	398,130 $27.3 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $3.16 Million - $3.85 Million	-44,096 Reduced 13.02%	294,640 $21.6 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $620,523 - $703,689	-8,469 Reduced 2.44%	338,736 $27.4 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $35.5 Million - $38.7 Million	-479,705 Reduced 58.01%	347,205 $26 Million
Q2 2023 May 17, 2024	BUY	$76.01 - $86.7 $40.5 Million - $46.1 Million	532,270 Added 180.65%	826,910 $63.7 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $29 Million - $33.1 Million	-381,738 Reduced 31.58%	826,910 $63.7 Million
Q1 2023 May 17, 2024	BUY	$77.31 - $88.08 $43 Million - $49 Million	556,288 Added 85.27%	1,208,648 $100 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $43 Million - $49 Million	556,288 Added 85.27%	1,208,648 $100 Million
Q4 2022 May 17, 2024	BUY	$62.32 - $89.47 $22.3 Million - $32 Million	357,720 Added 121.41%	652,360 $56 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $7.12 Million - $10.2 Million	114,296 Added 21.24%	652,360 $56 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $2.27 Million - $2.6 Million	-38,180 Reduced 6.63%	538,064 $33.2 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $4.6 Million - $5.18 Million	-79,649 Reduced 12.14%	576,244 $35.6 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $11 Million - $13.8 Million	190,033 Added 40.79%	655,893 $39 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $24.5 Million - $27.8 Million	-378,162 Reduced 44.8%	465,860 $34.2 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $9.85 Million - $10.6 Million	145,585 Added 20.84%	844,022 $59 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $28.7 Million - $31.4 Million	452,151 Added 183.59%	698,437 $48.1 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $16.7 Million - $19 Million	-277,907 Reduced 53.02%	246,286 $15.9 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $48 Million - $54.7 Million	-847,961 Reduced 61.8%	524,193 $29.9 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $1.93 Million - $2.42 Million	-31,020 Reduced 2.21%	1,372,154 $86.7 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $37 Million - $43 Million	-511,682 Reduced 26.72%	1,403,174 $108 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $24.1 Million - $30.9 Million	384,580 Added 25.13%	1,914,856 $143 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $18.3 Million - $20.2 Million	297,360 Added 24.12%	1,530,276 $99.4 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.48 Million - $1.64 Million	23,750 Added 1.96%	1,232,916 $78.1 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $37.4 Million - $41.9 Million	-604,232 Reduced 33.32%	1,209,166 $81.7 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $4.47 Million - $5.01 Million	-71,563 Reduced 3.8%	1,813,398 $118 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $61.8 Million - $80.7 Million	-1,021,453 Reduced 35.14%	1,884,961 $117 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $116 Million - $128 Million	1,621,623 Added 126.22%	2,906,414 $0
Q2 2018 Apr 15, 2019	BUY	$64.88 - $75.68 $397,844 - $464,069	6,132 Added 0.48%	1,284,791 $91 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $11.3 Million - $13.2 Million	-174,350 Reduced 12.0%	1,278,659 $90.6 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $23.5 Million - $28.7 Million	322,677 Added 28.55%	1,453,009 $107 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $3.84 Million - $4.51 Million	53,977 Added 5.01%	1,130,332 $81 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $77.6 Million - $92 Million	1,076,355	1,076,355 $87.2 Million

Others Institutions Holding GILD

# of Institutions

2,288

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $134B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Gilead Sciences, Inc. Transaction History